Cargando…
Biochemical screening for SARS-CoV-2 main protease inhibitors
The Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) pandemic represents a global challenge. SARS-CoV-2's ability to replicate in host cells relies on the action of its non-structural proteins, like its main protease (M(pro)). This cysteine protease acts by processing the viruses...
Autores principales: | Coelho, Camila, Gallo, Gloria, Campos, Claudia B., Hardy, Leon, Würtele, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537881/ https://www.ncbi.nlm.nih.gov/pubmed/33022015 http://dx.doi.org/10.1371/journal.pone.0240079 |
Ejemplares similares
-
A proteomics-MM/PBSA dual approach for the analysis of SARS-CoV-2 main protease substrate peptide specificity
por: Gallo, Gloria, et al.
Publicado: (2022) -
Screening, Synthesis and Biochemical Characterization of SARS-CoV-2 Protease Inhibitors
por: Bagdonas, Martynas, et al.
Publicado: (2023) -
Discovery of novel inhibitors against main protease (Mpro) of SARS-CoV-2 via virtual screening and biochemical evaluation
por: Guo, Sheng, et al.
Publicado: (2021) -
Structure-Based Virtual Screening and Biochemical
Validation to Discover a Potential Inhibitor of the SARS-CoV-2
Main Protease
por: Gupta, Akshita, et al.
Publicado: (2020) -
Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2
por: Tripathi, Praveen Kumar, et al.
Publicado: (2020)